Dr. Schlomm received his MD at the Georg-August University Göttingen, Germany in 2001, and finished his habilitation thesis in 2009 at the University Medical Center Hamburg-Eppendorf. He is currently full professor in urology and scientific director of the Martini-Clinic, Prostate Cancer Center at the University Medical Center Hamburg-Eppendorf (UKE).
Clinical validation of molecular prostate cancer markers are central topics of Dr. Schlomm’s research. In 2003, he established a prostate cancer biobank at the UKE, now consisting of over 20 000 prostate cancer samples, ready to use for molecular diagnostics. Together with Guido Sauter´s group, Dr. Schlomm developed a prostate cancer TMA including over 17 000 fully annotated prostate cancers. This TMA is one of the main resources for many translational research programs.
Dr. Schlomm has published more than 200 peer-reviewed scientific articles and received several honorary awards, among other the ASCO Merit Award and the Peter-Bischoff-Award Urology. His clinical expertise is underlined by his status as a high-volume surgeon, having performed more than 2000 radical prostatectomies, recently leading to the development of a new surgical technique, which now is becoming an international standard in prostate cancer surgery. At present, he is the clinical coordinator of the German ICGC (International Cancer Genome Consortium) and the TCGA (The Cancer Genome Atlas) prostate cancer genome sequencing projects.